国际麻醉学与复苏杂志   2020, Issue (6): 7-7
    
右美托咪定复合利多卡因术中静脉输注对胃癌根治术联合腹腔热灌注化疗患者白细胞介素‑6和肿瘤坏死因子‑α的影响
余析桐, 居霞, 王胜斌, 胡胜红, 徐四七, 李元海1()
1.安徽医科大学附属安庆医院
The effect of dexmedetomidine combined with lidocaine during intravenous infusion on interleukin‑6 and tumor necrosis factor‑α in patients undergoing radical gestrectomy for gastric cancer combined with intraperitoneal hyperthermic chemotherapy
 全文:
摘要:

目的 探究胃癌根治术联合腹腔热灌注的患者静脉应用利多卡因复合右美托咪定对机体炎性因子的影响。 方法 80例在气管插管静脉全身麻醉下接受根治性胃切除术(经腹全胃切除+食管空肠Roux‑en‑Y吻合)联合腹腔热灌注化疗(hyperthermic intraperitoneal chemotherapy, HIPEC)的患者,按随机数字表法分为对照组(C组)、右美托咪定组(D组)、利多卡因组(L组)、右美托咪定复合利多卡因组(DL组)(每组20例),诱导前10 min分别应用利多卡因、右美托咪定、利多卡因及右美托咪定复合使用、等容量生理盐水,然后持续泵注维持剂量至灌注结束前30 min。在诱导前(T1)、手术完成时(T2)、灌注治疗结束时(T3)、术后2 h(T4)、术后24 h(T5)5个时点收集静脉血液标本。记录并统计5个时点4组患者的血清IL‑6和TNF‑α的含量、苏醒与拔管时间、瑞芬太尼用量与丙泊酚用量。 结果 与C组比较,L组在T4和T5时血清TNF⁃α水平明显降低(P<0.05);D组和DL组在T2~T5时均出现血清IL⁃6和TNF‑α水平降低(P<0.05)。与L组比较,D组和DL组在T2~T5时血清IL⁃6和TNF⁃α水平降低(P<0.05)。与D组比较,DL组在T2~T5时血清IL⁃6和TNF⁃α水平降低(P<0.05)。与C组比较,L组苏醒与拔管所需时间、瑞芬太尼与丙泊酚用量差异无统计学意义(P>0.05),D组和DL组苏醒与拔管时间较长,且瑞芬太尼与丙泊酚用量较小(P<0.05)。与L组比较,D组和DL组苏醒与拔管时间较长;且瑞芬太尼与丙泊酚用量较小(P<0.05)。DL组苏醒与拔管所需时间明显长于D组,瑞芬太尼与丙泊酚用量明显小于D组(P<0.05)。 结论 右美托咪定及利多卡因的复合应用可以减轻胃癌根治术联合HIPEC所引起的炎性反应。

关键词: 利多卡因; 右美托咪定; 炎症因子; 胃癌根治术; 腹腔热灌注化疗
Abstract:

Objective This study observed the effect of lidocaine combined with dexmedetomidine on inflammatory factors in patients with gastric cancer undergoing intraperitoneal hyperthermic perfusion chemotherapy. Methods Eighty patients who received hyperthermic intraperitoneal chemotherapy (HIPEC) under general anesthesia for radical gastrectomy (Transabdominal total gastrectomy+Roux‑en‑Y anastomosis of esophagus and jejunum). The patients were randomly assigned into control group (group C), dexmedetomidine group (group D), lidocaine group (group L) and dexmedetomidine combined lidocaine group (group DL) (n=20). Intravenous pumping of the corresponding drugs 10 min before the induction of anesthesia, followed by continuous infusion until 30 min before the end of the perfusion. Peripheral venous blood was collected from patients before induction of anesthesia (T1), at the end of surgery (T2), at the end of perfusion (T3), 2 h (T4) and 24 h (T5) after surgery. The levels of serum interleukin (IL)‑6 and tumor necrosis factor‑α (TNF‑α) at T1, T2, T3, T4 and T5 in each group were measured. The serum IL‑6 and TNF‑α levels, recovery and extubation time, remifentanil and propofol consumption of patients in each group at T1, T2, T3, T4 and T5 were recorded and analyzed. Results Compared with group C, serum levels of TNF‑α were significantly reduced in group L at T4 and T5 (P<0.05), serum levels of IL‑6 and TNF‑α were significantly reduced in group D and group DL at T2‒T5 (P<0.05). Compared with group L, serum levels of IL‑6 and TNF‑α were significantly reduced in group D and group DL at T2‒T5 (P<0.05). Compared with group D, serum levels of IL‑6 and TNF‑α decreased in group DL at T2‒T5 (P<0.05). Compared with group C, the time required for recovery and extubation, and the dosage of remifentanil and propofol were not statistically different in group L (P>0.05), the time required for recovery and extubation was longer in group D and group DL, and the dosage of remifentanil and propofol was smaller (P<0.05). Compared with group L, the recovery and extubation time was longer in group D and group DL, and the dosage of remifentanil and propofol was smaller (P<0.05). The time required for recovery and extubation in group DL was significantly longer than that in group D, and the dosage of remifentanil and propofol was significantly less than that in group D (P<0.05). Conclusions Intravenous infusion of dexmedetomidine combined with lidocaine can reduce the inflammatory response caused by radical gastrectomy combined with HIPEC.

Key words: Lidocaine; Dexmedetomidine; Inflammatory factor; Radical gastrectomy; Hyperthermic intraperitoneal chemotherapy